{
  "variants": [
    {
      "gene": "SNCA",
      "protein_change": {
        "reference": "A",
        "alternate": "P",
        "position": 30
      },
      "variant_string_id": "SNCA A30P",
      "functional_evidence_strength": {
        "category": "PS3",
        "level": "very_strong"
      },
      "reasoning": {
        "step1": "The paper defines the disease mechanism: A30P is linked to Parkinson's disease and impairs membrane-binding activity, a key function of a-Syn.",
        "step2": "Membrane-binding assays (ultracentrifugation, spectroscopy, X-ray diffraction) are broadly accepted in the field.",
        "step3": {
          "substep3a": "The paper does not explicitly mention controls or replicates, but compares A30P to wild-type and A53T (normal activity), which may serve as implicit controls.",
          "substep3b": "The assays (ultracentrifugation, spectroscopy) are standard techniques, validating their use.",
          "substep3c": "The A53T variant (normal activity) acts as a control, contrasting with A30P's defective activity."
        },
        "step4": {
          "substep4a": "No OddsPath values are explicitly reported, but the comparison to wild-type and A53T (normal activity) provides strong functional evidence.",
          "substep4b": "The study includes at least two variant controls (wild-type and A53T), but the exact number is unspecified. However, the dominant effect of A30P over A53T in the double mutant suggests robust evidence."
        }
      }
    },
    {
      "gene": "SNCA",
      "protein_change": {
        "reference": "A",
        "alternate": "T",
        "position": 53
      },
      "variant_string_id": "SNCA A53T",
      "functional_evidence_strength": {
        "category": "BS3",
        "level": "very_strong"
      },
      "reasoning": {
        "step1": "The paper defines the disease mechanism: A53T is linked to Parkinson's disease but retains normal membrane-binding activity, contrasting with A30P's defective activity.",
        "step2": "Membrane-binding assays (ultracentrifugation, spectroscopy, X-ray diffraction) are broadly accepted in the field.",
        "step3": {
          "substep3a": "The paper does not explicitly mention controls or replicates, but compares A53T to wild-type and A30P (defective activity), which may serve as implicit controls.",
          "substep3b": "The assays (ultracentrifugation, spectroscopy) are standard techniques, validating their use.",
          "substep3c": "The A30P variant (defective activity) acts as a control, contrasting with A53T's normal activity."
        },
        "step4": {
          "substep4a": "No OddsPath values are explicitly reported, but the comparison to wild-type and A30P (defective activity) provides strong functional evidence.",
          "substep4b": "The study includes at least two variant controls (wild-type and A30P), but the exact number is unspecified. However, the normal activity of A53T despite being pathogenic suggests robust evidence."
        }
      }
    }
  ]
}